1. |
Herranz D, Serrano M. SIRT1:recent lessons from mouse models[J]. Nat Rev Cancer, 2010, 10(12):819-823.
|
2. |
de Boer VC, de Goffau MC, Arts IC, et al. SIRT1 stimulation by polyphenols is affected by their stability and metabolism[J]. Mech Ageing Dev, 2006, 127(7):618-627.
|
3. |
Deppert W. SIRT1 protein levels in cancer:tuning SIRT1 to the needs of a cancer cell[J]. Cell Cycle, 2008, 7(19):2947-2948.
|
4. |
Ford J, Jiang M, Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival[J]. Cancer Res, 2005, 65(22):10457-10463.
|
5. |
张广, 吴俊华. SIRT1与肿瘤的研究进展[J].世界华人消化杂志, 2013, 21(1):6-12.
|
6. |
Yin L, Wang X, Luo C, et al. The value of expression of M2-PK and VEGF in patients with advanced gastric cancer[J]. Cell Biochem Biophys, 2013, 67(3):1033-1039.
|
7. |
Jang KY, Hwang SH, Kwon KS, et al. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma[J]. Am J Surg Pathol, 2008, 32(10):1523-1531.
|
8. |
Alian A, Eldor A, Falk H, et al. Viral mediated gene transfer to sprouting blood vessels during angiogenesis[J]. J Virol Methods, 2002, 105(1):1-11.
|
9. |
Farhang Ghahremani M, Goossens S, Nittner D, et al. p53 prom-otes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway[J]. Cell Death Differ, 2013, 20(7):888-897.
|
10. |
Yang J, Ahmed A, Poon E, et al. Small-molecule activation of p53 blocks hypoxia-inducible factor 1alpha and vascular endoth-elial growth factor expression in vivo and leads to tumor cell apop-tosis in normoxia and hypoxia[J]. Mol Cell Biol, 2009, 29(8):2243-2253.
|
11. |
Yuan A, Yu CJ, Luh KT, et al. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer[J]. J Clin Oncol, 2002, 20(4):900-910.
|
12. |
Joo YE, Sohn YH, Joo SY, et al. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer[J]. Korean J Intern Med, 2002, 17(4):211-219.
|
13. |
傅玉峰, 丁炯. VEGF的表达与胃癌生物学特性的实验研究[J].南京医科大学学报:自然科学版, 2006, 26(9):749-752.
|
14. |
Knight JR, Milner J. SIRT1, metabolism and cancer[J]. Curr Opin Oncol, 2012, 24(1):68-75.
|
15. |
Jang KY, Noh SJ, Lehwald N, et al. SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas[J]. PLoS One, 2012, 7(9):e45119.
|
16. |
Deng CX. SIRT1, is it a tumor promoter or tumor suppressor?[J]. Int J Biol Sci, 2009, 5(2):147-152.
|
17. |
Chen HC, Jeng YM, Yuan RH, et al. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis[J]. Ann Surg Oncol, 2012, 19(6):2011-2019.
|
18. |
Yuan J, Pu M, Zhang Z, et al. Histone H3-K56 acetylation is important for genomic stability in mammals[J]. Cell Cycle, 2009, 8(11):1747-1753.
|
19. |
Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond[J]. Biochim Biophys Acta, 2010, 1804(8):1684-1689.
|
20. |
Cha EJ, Noh SJ, Kwon KS, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma[J]. Clin Cancer Res, 2009, 15(13):4453-4459.
|
21. |
Feng AN, Zhang LH, Fan XS, et al. Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance[J]. Int J Surg Pathol, 2011, 19(6):743-750.
|
22. |
Yuan J, Minter-Dykhouse K, Lou Z. A c-Myc-SIRT1 feedback loop regulates cell growth and transformation[J]. J Cell Biol, 2009, 185(2):203-211.
|
23. |
Chen WY, Wang DH, Yen RC, et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses[J]. Cell, 2005, 123(3):437-448.
|
24. |
Sun P, Yu H, Zhang WQ, et al. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo[J]. Oncol Rep, 2012, 28(5):1687-1692.
|
25. |
Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regu-lation of FOXO transcription factors by the SIRT1 deacetylase[J]. Science, 2004, 303(5666):2011-2015.
|
26. |
Johansson N, Ahonen M, Kähäri VM. Matrix metalloproteinases in tumor invasion[J]. Cell Mol Life Sci, 2000, 57(1):5-15.
|